134 related articles for article (PubMed ID: 30807398)
1. Two Occurrences of Leukemia Relapse Due to Mismatched HLA Loss After Haploidentical Stem Cell Transplantation From Different Family Donors With KIR Ligand Mismatch.
Sano H; Mochizuki K; Kobayashi S; Ono S; Ikeda K; Ohto H; Kikuta A
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e104-e106. PubMed ID: 30807398
[TBL] [Abstract][Full Text] [Related]
2. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.
Willemze R; Rodrigues CA; Labopin M; Sanz G; Michel G; Socié G; Rio B; Sirvent A; Renaud M; Madero L; Mohty M; Ferra C; Garnier F; Loiseau P; Garcia J; Lecchi L; Kögler G; Beguin Y; Navarrete C; Devos T; Ionescu I; Boudjedir K; Herr AL; Gluckman E; Rocha V;
Leukemia; 2009 Mar; 23(3):492-500. PubMed ID: 19151783
[TBL] [Abstract][Full Text] [Related]
3. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.
Ruggeri L; Mancusi A; Capanni M; Urbani E; Carotti A; Aloisi T; Stern M; Pende D; Perruccio K; Burchielli E; Topini F; Bianchi E; Aversa F; Martelli MF; Velardi A
Blood; 2007 Jul; 110(1):433-40. PubMed ID: 17371948
[TBL] [Abstract][Full Text] [Related]
4. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
5. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
6. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
Pende D; Marcenaro S; Falco M; Martini S; Bernardo ME; Montagna D; Romeo E; Cognet C; Martinetti M; Maccario R; Mingari MC; Vivier E; Moretta L; Locatelli F; Moretta A
Blood; 2009 Mar; 113(13):3119-29. PubMed ID: 18945967
[TBL] [Abstract][Full Text] [Related]
7. A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.
Piemontese S; Ciceri F; Labopin M; Arcese W; Kyrcz-Krzemien S; Santarone S; Huang H; Beelen D; Gorin NC; Craddock C; Gulbas Z; Bacigalupo A; Mohty M; Nagler A;
J Hematol Oncol; 2017 Jan; 10(1):24. PubMed ID: 28103944
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of high-dose
Lee JW; Kang ES; Sung KW; Yi E; Lee SH; Yoo KH; Koo HH
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 28012219
[TBL] [Abstract][Full Text] [Related]
9. Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.
Rocha V; Ruggeri A; Spellman S; Wang T; Sobecks R; Locatelli F; Askar M; Michel G; Arcese W; Iori AP; Purtill D; Danby R; Sanz GF; Gluckman E; Eapen M;
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1284-1289. PubMed ID: 27090957
[TBL] [Abstract][Full Text] [Related]
10. The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomes.
Stringaris K; Barrett AJ
Curr Opin Hematol; 2017 Nov; 24(6):489-495. PubMed ID: 28817402
[TBL] [Abstract][Full Text] [Related]
11. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias.
Beelen DW; Ottinger HD; Ferencik S; Elmaagacli AH; Peceny R; Trenschel R; Grosse-Wilde H
Blood; 2005 Mar; 105(6):2594-600. PubMed ID: 15536148
[TBL] [Abstract][Full Text] [Related]
12. Role of KIRs and KIR ligands in hematopoietic transplantation.
Velardi A
Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
[TBL] [Abstract][Full Text] [Related]
13. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
[TBL] [Abstract][Full Text] [Related]
14. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
[TBL] [Abstract][Full Text] [Related]
15. Natural killer-cell KIR repertoire reconstitution after haploidentical SCT.
Stern M; de Angelis C; Urbani E; Mancusi A; Aversa F; Velardi A; Ruggeri L
Bone Marrow Transplant; 2010 Nov; 45(11):1607-10. PubMed ID: 20173785
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
[TBL] [Abstract][Full Text] [Related]
17. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
19. Loss of mismatched HLA in myeloid/NK cell precursor acute leukemia relapse after T cell-replete haploidentical hematopoietic stem cell transplantation.
Kobayashi S; Kikuta A; Ito M; Sano H; Mochizuki K; Akaihata M; Waragai T; Ohara Y; Ogawa C; Ono S; Ohto H; Hosoya M
Pediatr Blood Cancer; 2014 Oct; 61(10):1880-2. PubMed ID: 24464971
[TBL] [Abstract][Full Text] [Related]
20. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]